Short CommunicationsFrequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma
Cited by (0)
Supported by US Department of Defense grant OC0400600 (to T.L.W.), Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (to V.E.V.), and NIH grants RO1-CA129080 (to I.M.S.), RO1-CA121113 (to V.E.V.), and RO1-CA116184 (to R.J.K.).
K.-T.K. and T.-L.M. contributed equally to this work.
D.S. is a member of the Genenetch and Sanofi-aventis Speakers Bureau.
Supplemental material for this article can be found on http://ajp.amjpathol.org.
Copyright © 2009 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.